2026 AAO Meeting: Minaker and Sambhara Discuss Trials InSight
Overview
At the 2026 AAO Meeting, Samuel Minaker, MD, MSc, and Deepak Sambhara, MD, FASRS, described Trials InSight as a virtual meeting intended to bring clinical-trial stakeholders together to share practices and learn from one another. The meeting is scheduled for February 27, 2027, with registration open and early-bird registration available through the end of November, according to the speakers.
Background
The speakers said they became involved in clinical trials to help bring new therapies to patients. They described trial work as a team effort involving investigators, research coordinators, sponsors, and contract research organizations (CROs). Trials InSight is intended to provide a forum for these groups, as well as pharmaceutical and biotechnology stakeholders, to share best practices. The speakers linked this collaboration to their stated aims of improving data generation, trial practices, and patient care.
Data Highlights
| Item | Details |
|---|---|
| Meeting | Trials InSight, virtual |
| Date | February 27, 2027 |
| Registration | Open at the time of the interview; early-bird registration offered for registrations before the end of November |
| Intended participants | Investigators, research coordinators, sponsors, CROs, pharmaceutical and biotechnology stakeholders |
Key Findings
- Minaker and Sambhara said their motivation for clinical-trial work is the opportunity to bring new therapies to patients.
- They characterized clinical trials as collaborative work involving investigators, coordinators, sponsors, and CROs.
- Trials InSight is planned as a virtual meeting on February 27, 2027.
- The speakers said the meeting will offer participants an opportunity to learn and share clinical-trial best practices.
- Sambhara described a recent event sponsored by Harrow that brought pharmaceutical and biotechnology stakeholders, research coordinators, and investigators together.
- The speakers stated that Trials InSight aims to elevate data generation, best practices, and the delivery of patient care.
Clinical Implications
The interview discusses the organizers’ goals for Trials InSight, a virtual meeting scheduled for February 27, 2027, and provides registration information.
Conclusion
Minaker and Sambhara describe Trials InSight as a virtual forum for clinical-research stakeholders to learn from one another and share best practices. The meeting is scheduled for February 27, 2027.
Related Resources & Content
- Optometric Management — Viewpoint
- The Medicine Maker — Trials of a Medicine Maker
- The Medicine Maker — Trials of a Medicine Maker
- the medicine maker — Trials of a Medicine Maker
- Preferred Practice Pattern® Guidelines: Ophthalmology
- Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration - Ophthalmology
- Four-Year Outcomes of Faricimab in Diabetic Macular Edema - Ophthalmology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







